Laddar...
3. How comprehensive can we be in the economic assessment of vaccines?
In two previous papers we argued on current vaccines economic assessment not fully comprehensive when using the incremental cost-utility analysis normally applied for treatments. Many differences exist between vaccines and drug treatments making vaccines economic evaluation more cumbersome. Four cha...
Sparad:
| I publikationen: | J Mark Access Health Policy |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Routledge
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956290/ https://ncbi.nlm.nih.gov/pubmed/29785253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2017.1336044 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|